DRÄGERWERK AG & CO. KGAA Financials Drägerwerk AG & Co. KGaA
Equities
DRW3
DE0005550636
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.85 EUR | -0.41% |
|
-1.41% | -5.69% |
| 04-25 | Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15 | DP |
| 04-25 | Transcript : Drägerwerk AG & Co. KGaA, Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 823 | 1,141 | 1,020 | 723.3 | 899.6 | 848.9 | - | - |
| Enterprise Value (EV) 1 | 911.7 | 1,328 | 995.9 | 982.5 | 1,097 | 973.4 | 1,026 | 751.4 |
| P/E ratio | 38.7 x | 6.13 x | 7.68 x | -12.2 x | 8.84 x | 10.6 x | 8.63 x | 6.41 x |
| Yield | 0.34% | 0.3% | 0.34% | 0.46% | 3.36% | 3.56% | 2.29% | 4.79% |
| Capitalization / Revenue | 0.3 x | 0.33 x | 0.31 x | 0.24 x | 0.27 x | 0.25 x | 0.24 x | 0.23 x |
| EV / Revenue | 0.33 x | 0.39 x | 0.3 x | 0.32 x | 0.33 x | 0.28 x | 0.28 x | 0.2 x |
| EV / EBITDA | 4.7 x | 2.55 x | 2.37 x | 17.6 x | 3.48 x | 3.15 x | 3.05 x | 1.86 x |
| EV / FCF | 8.9 x | 3.85 x | 3.63 x | -9.15 x | 8.97 x | 11.2 x | 8.97 x | 4.58 x |
| FCF Yield | 11.2% | 26% | 27.6% | -10.9% | 11.1% | 8.92% | 11.1% | 21.9% |
| Price to Book | 0.92 x | - | 0.82 x | 0.59 x | 0.69 x | 0.62 x | 0.59 x | - |
| Nbr of stocks (in thousands) | 17,712 | 18,655 | 18,671 | 18,651 | 18,760 | 18,760 | - | - |
| Reference price 2 | 55.70 | 62.80 | 55.25 | 41.75 | 51.80 | 48.85 | 48.85 | 48.85 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 16/03/23 | 07/03/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,781 | 3,406 | 3,328 | 3,045 | 3,374 | 3,460 | 3,611 | 3,730 |
| EBITDA 1 | 193.8 | 521 | 421 | 55.8 | 315 | 309.5 | 335.9 | 404.4 |
| EBIT 1 | 66.58 | 396.6 | 271.7 | -88.61 | 166.4 | 153.6 | 178.7 | 221.8 |
| Operating Margin | 2.39% | 11.64% | 8.16% | -2.91% | 4.93% | 4.44% | 4.95% | 5.95% |
| Earnings before Tax (EBT) 1 | 49.53 | 360.2 | 236.6 | -102.4 | 141.3 | 123.8 | 156.2 | 206.4 |
| Net income 1 | 33.35 | 250.2 | 154.2 | -64.56 | 110.4 | 86.67 | 106.1 | 143 |
| Net margin | 1.2% | 7.34% | 4.63% | -2.12% | 3.27% | 2.51% | 2.94% | 3.83% |
| EPS 2 | 1.440 | 10.25 | 7.190 | -3.410 | 5.860 | 4.620 | 5.660 | 7.620 |
| Free Cash Flow 1 | 102.4 | 345 | 274.5 | -107.4 | 122.3 | 86.8 | 114.3 | 164.2 |
| FCF margin | 3.68% | 10.13% | 8.25% | -3.53% | 3.63% | 2.51% | 3.17% | 4.4% |
| FCF Conversion (EBITDA) | 52.84% | 66.23% | 65.21% | - | 38.83% | 28.05% | 34.04% | 40.6% |
| FCF Conversion (Net income) | 307.05% | 137.93% | 178.01% | - | 110.75% | 100.15% | 107.73% | 114.83% |
| Dividend per Share 2 | 0.1900 | 0.1900 | 0.1900 | 0.1900 | 1.740 | 1.740 | 1.117 | 2.340 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 16/03/23 | 07/03/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,428 | 1,633 | 649.5 | 652.9 | 1,302 | - | 761.1 | 771.3 | 1,532 | 788.5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT | 101.6 | 209.2 | - | -76.61 | -111.7 | - | - | - | - | - |
| Operating Margin | 7.11% | 12.81% | - | -11.73% | -8.58% | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | -26.91 | - | - | - | 17.04 | 10.72 | 27.75 | - |
| Net margin | - | - | -4.14% | - | - | - | 2.24% | 1.39% | 1.81% | - |
| EPS | - | - | - | - | - | -1.860 | - | 0.5700 | 1.470 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 13/08/20 | 29/07/21 | 28/04/22 | 28/07/22 | 28/07/22 | 27/10/22 | 28/04/23 | 27/07/23 | 27/07/23 | 02/11/23 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 88.7 | 187 | - | 259 | 198 | 125 | 177 | - |
| Net Cash position 1 | - | - | 24 | - | - | - | - | 97.5 |
| Leverage (Debt/EBITDA) | 0.4577 x | 0.3591 x | - | 4.645 x | 0.6276 x | 0.4024 x | 0.5275 x | - |
| Free Cash Flow 1 | 102 | 345 | 275 | -107 | 122 | 86.8 | 114 | 164 |
| ROE (net income / shareholders' equity) | 3.1% | 23.7% | 13.5% | -5.01% | 8.11% | 5.8% | 6.87% | 8.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 60.50 | - | 67.20 | 70.30 | 75.00 | 78.50 | 83.50 | - |
| Cash Flow per Share | 7.080 | - | - | - | - | - | - | - |
| Capex 1 | 58.5 | 115 | 110 | - | 68.2 | 80 | 100 | 106 |
| Capex / Sales | 2.1% | 3.37% | 3.32% | - | 2.02% | 2.31% | 2.77% | 2.83% |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 16/03/23 | 07/03/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
48.85
EUR
Average target price
56.25
EUR
Spread / Average Target
+15.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.69% | 906M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- DRW3 Stock
- Financials Drägerwerk AG & Co. KGaA
